Transurethral Resection and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer
Status:
Terminated
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so
they stop growing or die. Combination chemotherapy combined with transurethral resection may
kill more tumor cells.
PURPOSE: Phase II trial to study the effectiveness of transurethral resection plus
combination chemotherapy in treating patients who have stage II or stage III bladder cancer.
Phase:
Phase 2
Details
Lead Sponsor:
European Organisation for Research and Treatment of Cancer - EORTC